Is Cogent Biosciences, Inc. overvalued?

Cogent Biosciences, Inc. (COGT) — key valuation metrics and fundamentals.

No verdict

Price

$28.56

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$4.97B

Dividend yield

0.0%

Return on equity

-71.1%

Sector

Healthcare

Fair value compares COGT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks